======= LRP10 ======= == Gene Information == * **Official Symbol**: LRP10 * **Official Name**: LDL receptor related protein 10 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26020|26020]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z4F1|Q7Z4F1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LRP10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LRP10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609921|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a low density lipoprotein receptor family protein. A similar protein in mouse is thought to play a role in the uptake of apolipoprotein E-containing lipoproteins. [provided by RefSeq, Jul 2016]. * **UniProt Summary**: N/A |Ldl recept a| |CUB| |low-density lipoprotein particle receptor activity| |clathrin-coated pit| |inner ear development| |ear development| |lipid transport| |lipid localization| |sensory organ development| |endocytosis| |import into cell| |lipid metabolic process| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-2.61| |[[:results:exp17|DABN 20μM R00 exp17]]|-2.59| |[[:results:exp210|LB-100 2μM R05 exp210]]|-2.43| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-2.31| |[[:results:exp31|Rifampicin 1μM R00 exp31]]|-2.1| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-2.04| |[[:results:exp326|CCT251545 20μM R07 exp326]]|-1.86| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.84| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.77| |[[:results:exp115|A-366 10μM R03 exp115]]|-1.76| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.76| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.75| |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|-1.75| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-1.72| |[[:results:exp141|Nifurtimox 1μM R03 exp141]]|-1.7| |[[:results:exp406|Thalidomide 20μM R07 exp406]]|1.72| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|2.39| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.61| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17237 * **Expression level (log2 read counts)**: 7.39 {{:chemogenomics:nalm6 dist.png?nolink |}}